Independent Portfolio Consultants, Inc. - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.

Quarter-by-quarter ownership
Independent Portfolio Consultants, Inc. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$8,000
-99.0%
45
-99.3%
0.00%
-99.1%
Q2 2014$778,000
+3.2%
6,305
-13.5%
0.22%
-8.8%
Q1 2014$754,000
-25.6%
7,285
-35.3%
0.24%
-32.5%
Q4 2013$1,013,000
+36.2%
11,260
+1.2%
0.35%
+18.8%
Q3 2013$744,000
-0.8%
11,125
-1.9%
0.30%
-11.3%
Q2 2013$750,00011,3450.34%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$46,872,00024.29%
HealthCor Management, L.P. 935,100$146,100,0007.50%
1492 Capital Management LLC 70,167$10,963,0006.07%
Visium Asset Management, LP 2,301,629$359,607,0005.31%
HWG Holdings LP 39,621$6,190,0004.97%
Riggs Asset Managment Co. Inc. 45,649$7,132,0004.14%
Cardinal Capital Management 49,139$7,677,0003.65%
AMI ASSET MANAGEMENT CORP 213,398$33,341,0003.27%
BENNETT LAWRENCE MANAGEMENT L L C/NY 88,435$13,817,0003.14%
Adamant Biomedical Investments AG 78,210$12,220,0003.05%
View complete list of SALIX PHARMACEUTICALS INC shareholders